References

• Behari, M., Srivastava, A. K., & Pandey, R. M. (2005). Quality of life in patients with Parkinson’s disease. Parkinsonism & Related Disorders, 11(4), 221–226. https://doi.org/10.1016/j.parkreldis.2004.12.005
• DeMaagd, G., & Philip, A. (2015). Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. Pharmacy and Therapeutics, 40(8), 504. https://pubmed.ncbi.nlm.nih.gov/26236139/
• Hanning, U., Teuber, A., Lang, E., Trenkwalder, C., Mollenhauer, B., & Wersching, H. (2019). White matter hyperintensities are not associated with cognitive decline in early Parkinson’s disease – The DeNoPa cohort. Parkinsonism & Related Disorders, 69, 61–67. https://doi.org/10.1016/j.parkreldis.2019.10.016
• Hunt, J. P., Coulson, E. J., Rajnarayanan, R., Oster, H., Videnovic, A., & Rawashdeh, O. (2022). Sleep and circadian rhythms in Parkinson’s disease and preclinical models. Molecular Neurodegeneration, 17(1). https://doi.org/10.1186/s13024-021-00504-w
• Keir, L. S., & Breen, D. E. (2019). New awakenings: current understanding of sleep dysfunction and its treatment in Parkinson’s disease. Journal of Neurology, 267(1), 288–294. https://doi.org/10.1007/s00415-019-09651-z
• Li, X., Yu, Y., & Tu, Z. (2021). Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer’s Disease and Parkinson’s Disease Treatment (2011–2020). Molecules, 26(5), 1202. https://doi.org/10.3390/molecules26051202
• Martínez-Arán, A., Vieta, E., Colom, F., Torrent, C., Sánchez, J., Reinares, M., Benabarre, A., Goikolea, J. M., Brugue, E., Daban, C., & Salamero, M. (2004). Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disorders, 6(3), 224–232. https://doi.org/10.1111/j.1399-5618.2004.00111.x
• Masterman, D., & Swanberg, M. (2003). Neurologic aspects of dementia with Lewy bodies and Parkinson’s disease with dementia: John Wiley & Sons., New Jersey.
• Idziak, M.-, & Marie, N. (2021). Toward Precision Medicine: Effects of the Common VAL66met BDNF Variant in the Aging Brain and Implications for the Future of Parkinson’S Disease Therapeutics. ProQuest Dissertations Publishing. https://www.proquest.com/openview/04cd4f55be20e3b502314676361d1131/1?pq-origsite=gscholar&cbl=18750&diss=y
• Milner, R., Lewandowska, M., Ganc, M., WÅ‚odarczyk, E., GrudzieÅ„, D., & SkarżyÅ„ski, H. (2018). Abnormal Resting-State Quantitative Electroencephalogram in Children With Central Auditory Processing Disorder: A Pilot Study. Frontiers in Neuroscience, 12. https://doi.org/10.3389/fnins.2018.00292
• Mollayeva, T., Thurairajah, P., Burton, K., Mollayeva, S., Shapiro, C. M., & Colantonio, A. (2016). The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non- clinical samples: A systematic review and meta- analysis. Sleep Medicine Reviews, 25, 52–73. https://doi.org/10.1016/j.smrv.2015.01.009
• Most, E. I. S., Aboudan, S., Scheltens, P., & Van Someren, E. J. (2012). Discrepancy Between Subjective and Objective Sleep Disturbances in Early- and Moderate-Stage Alzheimer Disease. American Journal of Geriatric Psychiatry, 20(6), 460–467. https://doi.org/10.1097/jgp.0b013e318252e3ff
• Rewar, S. (2015). A systematic review on Parkinson's disease (PD). Indian Journal of Research in Pharmacy and Biotechnology, 3(2), 176.
• Rinehart, N. J., Bradshaw, J. L., & Enticott, P. G. (2016). Developmental Disorders of the Brain. https://doi.org/10.4324/9781315692289
• Santos-García, D., De Deus Fonticoba, T., Bartolomé, C. P., Painceiras, M. F., Castro, E. S., Canfield, H., Miró, C. M., Jesús, S., Aguilar, M., Pastor, P., Planellas, L., Cosgaya, M., Caldentey, J., Caballol, N., Legarda, I., Hernández-Vara, J., Cabo, I., Manzanares, L. L., Aramburu, I. G., . . . Group, N. P. S. (2022). Motor Fluctuations Development Is Associated with Non-Motor Symptoms Burden Progression in Parkinson’s Disease Patients: A 2-Year Follow-Up Study. Diagnostics, 12(5), 114 https://doi.org/10.3390/diagnostics12051147
• Schindlbeck, K. A., Vo, A., Mattis, P. J., Villringer, K., Marzinzik, F., Fiebach, J. B., & Eidelberg, D. (2021). Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network.Cerebral Cortex, 31(11), 5139–5150. https://doi.org/10.1093/cercor/bhab148
• Schrag, A., Jahanshahi, M., & Quinn, N. (2000). How does Parkinson’s disease affect quality of life? A comparison with quality of life in the general population. Movement Disorders, 15(6), 1112– 1118. https://doi.org/10.1002/1531- 8257(200011)15:6
• Vieta, E., Jiménez, E., Torrent, C., Reinares, M., Del Mar Bonnín, C., Torres, I., Varo, C., Grande, I., Valls, E., Salagre, E., Sánchez, J., Martínez-Arán, A., Carvalho, A. F., & Vieta, E. (2017). Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies. The International Journal of Neuropsychopharmacology, 20(8), 670– 680. https://doi.org/10.1093/ijnp/pyx032
• Tan, A. H., Chuah, K. H., Beh, Y. Y., Schee, J. P., Mahadeva, S., & Lim, S.-Y. (2023). Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem. Journal of movement disorders, 16(2), 138.
• Van Hilten, B. (1994). Sleep Disruption in Parkinson’s Disease. Archives of Neurology, 51(9), 922. https://doi.org/10.1001/archneur.1994.00540 210094018